title: Complications after colorectal anastomosis in a patient with metastatic rectal cancer treated with systemic chemotherapy and bevacizumab.
authors.affiliation: Department of Surgery, Maisonneuve-Rosemont Hospital, University of Montreal, Montréal, Que.
authors.forename: Amine
authors.initials: A
authors.lastname: Akkouche
authors.forename: Lucas
authors.initials: L
authors.lastname: Sidéris
authors.forename: Guy
authors.initials: G
authors.lastname: Leblanc
authors.forename: Yves-E
authors.initials: YE
authors.lastname: Leclerc
authors.forename: Petro
authors.initials: P
authors.lastname: Vafiadis
authors.forename: Pierre
authors.initials: P
authors.lastname: Dubé
mesh_terms: D000714:Anastomosis, Surgical; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D003106:Colon / Q000601:surgery; D003131:Combined Modality Therapy; D000075202:Contraindications; D013505:Digestive System Surgical Procedures; D006801:Humans; D007813:Laparotomy; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D012007:Rectum / Q000601:surgery; D013997:Time Factors
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab